The Dental Elf

Bisphosphonate osteonecrosis (BON)

The American Dental Association Center for Evidence-Based Dentistry has  just completed a critical review of a  paper by Migliorati et al published in 2012 which aimed to examine the prevalence of bisphosphonate osteonecrosis (BON) in the cancer population, prevention and treatment protocols, and quality of life issues.

This is a growing area of interest but, as the review notes the existing research at this time is limited  so dentists need to remain vigilant for BON and help to avert it.  Helpful guidance  is available from the  bisphosphonate page of the SDCEP  (Scottish Dental Clinical Effectiveness Programme) website .

Go to the ADA summary

Migliorati CA, Woo SB, Hewson I, Barasch A, Elting LS, Spijkervet FK, Brennan  MT; Bisphosphonate Osteonecrosis Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer. 2010 Aug;18(8):1099-106. Epub 2010 Apr 22. Review. PubMed PMID: 20411279.

 

Add a comment
  • Bisphosphonate-related osteonecrosis of the jaw treatments - The Dental Elf

    Bisphosphonate-related osteonecrosis of the jaw treatments - The Dental Elf

    11 years ago
    […] Dental Elf – 6th Feb 2012- Bisphosphonate osteonecrosis (BON) […]
  • Intravenous bisphosphonates and osteonecrosis of the jaw » The Dental Elf

    Intravenous bisphosphonates and osteonecrosis of the jaw » The Dental Elf

    13 years ago
    [...] [...]